MA Klinische Immunologie

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Vlaar, A. P. J., Witzenrath, M., van Paassen, P., Heunks, L. M. A., Mourvillier, B., de Bruin, S., Lim, E. H. T., Brouwer, M. C., Tuinman, P. R., Saraiva, J. F. K., Marx, G., Lobo, S. M., Boldo, R., Simon-Campos, J. A., Cornet, A. D., Grebenyuk, A., Engelbrecht, J. M., Mukansi, M., Jorens, P. G., Zerbib, R., & 6 othersRückinger, S., Pilz, K., Guo, R., van de Beek, D., Riedemann, N. C. & PANAMO study group, 7 Sept 2022, (E-pub ahead of print) In: The Lancet Respiratory medicine. 10, 12, p. 1137-1146
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Arteritis Status and Renal Involvement in ANCA-Associated Vasculitis
Limburg Renal Registry, 6 Jan 2022, (E-pub ahead of print) In: Journal of the American Society of Nephrology. 33, 2, p. 457-458 2 p.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Web of Science)
B-Cell Analysis for Monitoring Patients Undergoing B-Cell Depletion for the Treatment of Autoimmune Diseases
Damoiseaux, J. G. M. C., van Beers, J. J. B. C., Busch, M. & van Paassen, P., 2022, Therapeutic Antibodies. Vol. 2313. p. 45-55 11 p. (Methods in Molecular Biology).
Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Profiles